欢迎访问《中国实验方剂学杂志》编辑部网站!
姜黄素纳米混悬剂在大鼠体内药代动力学考察
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

江苏省中医药研究院项目(BK201023126)


In vivo Pharmacokinetics Investigation of Curcumin Nanosuspensions in Rats
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的: 探讨姜黄素纳米混悬剂在大鼠体内的药代动力学过程。方法: 将同等剂量的姜黄素原料药与姜黄素纳米混悬剂分别灌胃给2组大鼠,于灌胃后20,40 min和1,2,4,6,8,12,24 h眼底静脉丛取血,采用HPLC测定血浆姜黄素含量,Xterra C18色谱柱(4.6 mm×250 mm,5 μm),C18预柱(4.0 mm×2.0 mm),柱温35℃,流动相甲醇-1%乙酸水溶液(78:22),流速1.0 mL·min-1,进样量20 μL,计算姜黄素最低定量限,同时测定血浆中姜黄素原料药与姜黄素纳米混悬剂的药代动力学参数。结果: 血浆中姜黄素的定量限15 μg·L-1(S/N>10),低、中、高质量浓度的提取回收率(x±s,n=5)分别为(91.3±5.7)%,(93.0±4.1)%,(93.3±5.2)%。姜黄素纳米混悬剂的Cmax和AUC均显著高于姜黄素原料,Cmax分别为(863.1±390.4),(91.8±22.9) μg·L-1;原料药和混悬剂的Tmax分别为(4.4±2.2),(4.8±4.4) h,t1/2分别为(4.6±3.2),(5.4±3.7) h,均无显著性变化。结论: 建立的HPLC分析条件稳定可靠,纳米混悬剂能明显促进姜黄素的吸收,提高其生物利用度,但吸收和代谢速度无明显差异。

    Abstract:

    Objective: To investigate in vivo pharmacokinetics and oral bioavailability of curcumin nanosuspensions in rats. Method: The same dose of curcumin bulk drugs and curcumin nanosuspensions were orally administered to two groups of rats,After gavage 20,40 min,1,2,4,6,8,12,24 h,0.3 mL blood from retinal venous plexus was obtained to measure plasma curcumin concertration ny HPLC analysis,Xterra C18 column(4.6 mm×250 mm,5 μm),C18 pre-column(4.0 mm×2.0 mm),column temperature 35℃,mobile phase of methanol-1% acetic acid aqueous solution(78:22),flow rate 1.0 mL·min-1,injection volume 20 μL.The lowest limit of quantitation of curcumin and other pharmacokinetic parameters of curcumin and curcumin nanosuspensions were determined. Result: Quantification limit of curcumin in plasma was 15 μg·L-1(S/N>10),extraction recoveries of low,medium and high concentration were (91.3±5.7)%,(93.0±4.1)%,(93.3±5.2)%,respectively.Cmax and AUC of curcumin nanosuspensions were higher than that of curcumin bulk drugs,Cmax were (863.1±390.4),(91.8±22.9) μg·L-1;Tmax of curcumin bulk drugs and curcumin nanosuspensions were (4.4±2.2) h and (4.8±4.4) h,t1/2 were (4.6±3.2) h and (5.4±3.7) h,there was no significant change of these two parameters. Conclusion: Established HPLC analysis was reliable and stable,curcumin nanosuspensions could significantly promote absorption of curcumin and improve its bioavailability,but no significant differences were found in both absorption and metabolic.

    参考文献
    相似文献
    引证文献
引用本文

钟荣玲,夏智,武洁,宋捷,王大为,黄厚才.姜黄素纳米混悬剂在大鼠体内药代动力学考察[J].中国实验方剂学杂志,2013,19(20):137~139

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2013-01-09
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2013-10-13
  • 出版日期:

地址:北京东直门内南小街16号

邮编:100700

电话:010-84076882

E-mail:syfjx_2010@188.com

中国实验方剂学杂志 ® 2024 版权所有

技术支持:北京勤云科技发展有限公司